When "newborn jitters" turned out to be a rare brain condition, Veronica Monclova fought for the surgery that saved her ...

Teacher Yareli Jessica Gijon tells PEOPLE how she manages epilepsy in the classroom and why she posted a seizure video to ...

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes ...

Eight Northwestern researchers published a study April 29 detailing how RNA therapy could be used before birth to combat a ...

A seizure can be scary. And when you’re already living with multiple sclerosis (MS), it’s easy to wonder whether the episode could somehow be related — and if you now have a new symptom you’ll need to ...

Epilepsy is a neurological disorder that causes temporary brain dysfunction. The aftermath of an epileptic seizure varies for each individual and depends on its severity. FITBOOK outlines types of ...

Dr. Aziza Glass is a Doctor of Veterinary Medicine graduate from Cornell University. She was born in Houston, Texas, and nurtured her love of animals by watching television documentaries and ...

Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in ...

Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time points X-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in ...

Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more than 50% for some patients as it looks to position itself to become the ...

X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo (p=0.000000000006 ...